Publications by authors named "Paula Marti Torrell"

Chimeric antigen receptor (CAR)-T cell therapy is rapidly advancing as cancer treatment, however, designing an optimal CAR remains challenging. A single-chain variable fragment (scFv) is generally used as CAR targeting moiety, wherein the complementarity-determining regions (CDRs) define its specificity. We report here that the CDR loops can cause CAR clustering, leading to antigen-independent tonic signalling and subsequent CAR-T cell dysfunction.

View Article and Find Full Text PDF

Functional consequences of genetic variation in the noncoding human genome are difficult to ascertain despite demonstrated associations to common, complex disease traits. To elucidate properties of functional noncoding SNPs with effects in human endothelial cells (ECs), we utilized our previous molecular quantitative trait locus (molQTL) analysis for transcription factor binding, chromatin accessibility, and H3K27 acetylation to nominate a set of likely functional noncoding SNPs. Together with information from genome-wide association studies (GWASs) for vascular disease traits, we tested the ability of 34,344 variants to perturb enhancer function in ECs using the highly multiplexed STARR-seq assay.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Paula Marti Torrell"

  • - Recent research by Paula Marti Torrell focuses on the molecular mechanisms underlying CAR-T cell therapy efficacy and the impact of genetic variants on vascular health.
  • - One key finding indicates that clustering of complementarity-determining regions (CDRs) in CAR-T cells may lead to dysfunction due to antigen-independent tonic signaling, highlighting challenges in the design of effective CARs for cancer treatment.
  • - Additionally, her work on functional noncoding SNPs in human endothelial cells reveals their role in vascular trait associations, utilizing advanced genomic techniques to identify variants that may disrupt enhancer function and linking these findings to common vascular diseases.